Celltrion Expands Pediatric Options with New STEQEYMA® Presentation Approval Celltrion has received FDA approval for a new STEQEYMA® presentation, offering flexible dosing for pediatric patients with psoriasis and arthritis.

Celltrion Expands Pediatric Options with New STEQEYMA® Presentation Approval #South_Korea #FDAApproval #Incheon #Celltrion #STEQEYMA

Celltrion's autoimmune disease treatment hits 5 major European countries - Yes Punjab News Celltrion launches its autoimmune disease treatment SteQeyma in five major European countries, following European Commission approval. The company aims for significant growth with expanded sales and a...

Celltrion's autoimmune disease treatment hits 5 major European countries
yespunjab.com?p=85477

#Celltrion #AutoimmuneTreatment #SteQeyma #EuropeanLaunch #HealthNews #Biosimilars #ChronicDiseases #Gastroenterology #Dermatology #Rheumatology